Efficacy and tolerability of the non-benzodiazepine antispasmodic methocarbamol for the short-term treatment of acute low back pain over 3 days - results of a patient-level pooled re-analysis of depersonalized data from two double-blind randomized placebo-controlled clinical trials evaluating oral and intravenous use. (METABO)

07/12/2022
23/04/2024
EU PAS number:
EUPAS50070
Study
Ongoing

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other

Data sources (types), other

Patient-level pooled re-analysis of already existing depersonalized raw data from two clinical trials performed in 2002/2003.
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No
Procedures
No information provided.